JF
ENZ

Jump Financial’s Enzo Biochem, Inc. ENZ Stock Holding History

Jump Financial’s Portfolio ENZ Stock Details ENZ Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q3 		– Sell
-39,000
Closed -$124K – 1579
2021
Q2 		$124K Buy
+39,000
New +$123K 0.01% 956

Other funds holding ENZ

HFA
Harbert Fund Advisors Birmingham, Alabama $3.03M AUM 40.55% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
RAM
Roumell Asset Management Chevy Chase, Maryland $53.3M AUM 8.91% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
EGA
Evermore Global Advisors Summit, New Jersey $26.3M AUM 7.42% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCA
VIEX Capital Advisors Sunny Isles Beach, Florida $30.9M AUM 55.48% 1-Year Est. Return
Fuller & Thaler Asset Management
Fuller & Thaler Asset Management San Mateo, California $29.7B AUM 43.33% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Jump Financial's ENZ Position: Q3 2021 in Review

Jump Financial sold out of Enzo Biochem, Inc. (ENZ) in Q3 2021, closing a stake of 39,000 shares — an estimated $124K sold.

Jump Financial first reported a position in ENZ in Q2 2021 and held it in 1 quarter. The position peaked at $124K in Q2 2021. 65 funds tracked by Wall St. Rank hold ENZ as of Q3 2021.

  • Jump Financial reported no remaining Enzo Biochem, Inc. position as of Q3 2021 after selling out during the quarter.
  • Jump Financial sold 39,000 Enzo Biochem, Inc. shares in Q3 2021, an estimated $124K.
  • Jump Financial first reported a position in Enzo Biochem, Inc. in Q2 2021 and held it in 1 quarter.
  • Jump Financial's Enzo Biochem, Inc. position peaked at $124K in Q2 2021.
  • 65 funds tracked by Wall St. Rank held Enzo Biochem, Inc. as of Q3 2021.

Based on Jump Financial's 13F filing for Q3 2021, filed 12 Nov 2021.